Positioning system for Dotplot (an at-home breast health monitoring device)

在英国，每7名女性中至少有1人会在有生之年被诊断出患有乳腺癌，每天都有31名女性死于乳腺癌。然而，如果及早诊断，存活率为93%，这就是为什么定期乳房自我检查至关重要。不幸的是，女性往往依赖于演示、教程和小册子，所有这些都提出了不同的方法。缺乏适当的指导和反馈导致不坚持自我检查。许多女性很难理解她们乳房的感觉，因此不敢进行常规检查。DotPlot旨在消除猜测，鼓励人们坚持常规做法。DotPlot是一款面向消费者的家庭乳房健康监测工具，旨在帮助女性自信地护理乳房。它结合了一个手持设备和能够读取、定位和记录乳房健康数据的软件。该公司正在申请专利的技术指导女性每月进行乳房自我检查，并对乳房组织进行逐月比较。这有助于及早标记异常的发展，并确保女性及时达到她们的全科医生。有了创新英国的快速启动：创新拨款，DotPlot将能够开发其核心功能之一，即定位手持设备相对于躯干的位置，并在移动应用程序中提供屏幕反馈和指导。目的是使女性能够定期参与到她们的乳房健康中，从而减少乳腺癌的死亡人数。

At least 1 in 7 women in the UK will be diagnosed with breast cancer within their lifetime and 31 women die of it every single day. However, there is a 93% chance of survival if diagnosed early, which is why regular breast self-checks are vital. Unfortunately, women are often dependent on demonstrations, tutorials, and pamphlets, all proposing different methods. Lack of proper guidance and feedback results in non-adherence to self-checks. Many women struggle to interpret what they feel in their breasts hence deterring them from doing regular checks. Dotplot aims to eliminate the guesswork and encourage adherence to a regular routine.Dotplot is a consumer-facing at-home breast health monitoring tool designed to help women look after their breasts with confidence. It combines a handheld device and software that is capable of reading, locating, and recording breast health data. Its patent-pending technology guides women through breast self-checks on a monthly basis and creates month-by-month comparisons of breast tissue. This helps to flag the development of abnormalities as early as possible and ensure women reach their GPs in time.With Innovate UK's Fast Start: Innovation grant, Dotplot will be able to develop one of its core features which is locating the position of the handheld device when held against the torso and providing on-screen feedback and guidance within the mobile application.The aim is to empower women to engage with their breast health on a routine basis and in turn, reduce the number of deaths per incidence of breast cancer.